Preliminary results from the phase-one trial indicate promise for patient safety and positive patient outcomes.
The company expects to commence enrollment in the randomized, double-blinded, placebo-controlled trial in the fourth quarter of 2012. Interim results are expected by the end of 2013.
More Articles on Orthopedic Devices:
Globus Medical to Showcase New Spine Surgery Products
Paradigm Spine, OM HealthCare Sign Multiyear Logistics Agreement
Integra LifeSciences Launches Complete Cervical Interbody Fusion Device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.